HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

PD 169316

p38 MAP kinase inhibitor
Also Known As:
4-(4-fluorophenyl)-2-(4-nitrophenyl)-5-(4-pyridyl)-1H-imidazole; PD-169316; PD169316
Networked: 9 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Jeong, Hoiseon: 1 article (01/2013)
2. Kim, Hankyeom: 1 article (01/2013)
3. Lee, Youngseok: 1 article (01/2013)
4. Kim, Aeree: 1 article (01/2013)
5. Kim, Chungyeul: 1 article (01/2013)
6. Kim, Jinkyoung: 1 article (01/2013)
7. Ashabi, Ghorbangol: 1 article (06/2012)
8. Ramin, Mahmoudreza: 1 article (06/2012)
9. Khodagholi, Fariba: 1 article (06/2012)
10. Ansari, Niloufar: 1 article (06/2012)

Related Diseases

1. Chondrosarcoma
2. Prostatic Neoplasms (Prostate Cancer)
3. Memory Disorders (Memory Loss)
4. Leukemia
5. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. Phosphotransferases (Kinase)
2. 4- (4- fluorophenyl)- 2- (4- hydroxyphenyl)- 5- (4- pyridyl)imidazole
3. U 0126 (UO 126)
4. Calpain
5. Amyloid (Amyloid Fibrils)
6. p38 Mitogen-Activated Protein Kinases
7. SB 203580
8. Mitogen-Activated Protein Kinase Kinases (MEKs)
9. Staurosporine
10. Cadmium Chloride (Cadmium Dichloride)